Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Granisetron manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Mexico

Clear all

1 products found

granisetron

Injection 3 mg / 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18736
It was founded in the 2000s. The main aim of the position itself in the market as a company dedicated to the research, development, manufacturing, marketing, and distribution of new generation specialized generic and biosimilar medicines.

Manufacturer usually replies in 7 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Granisetron Manufacturers

Markets of interest

Granisetron is an antiemetic and antinauseant for cancer chemotherapy patients. As a serotonin receptor (5HT-3 selective) antagonist that has been used the substance blocks the actions of chemicals in the body that can trigger nausea and vomiting. The medication is used to prevent nausea and vomiting that may be caused by medicine to treat cancer (chemotherapy or radiation). The substance is available for sale in the form of ampoules, tablets, film-coated, tablets, vials, solution for infusion, solution for injection/infusion, from manufacturers in various countries including Y. The drug is provided by a wide range of Granisetron suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Granisetron manufacturers and distributors are based in India, China, and Turkey.

Licensing and brand names

Granisetron was approved by the FDA for use in the USA in 2020. In 2011 under the trade name Kytril, the medication was approved by the EMA in the European Union. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Granisetron Hydrochloride, Kytril. One of the most popular branded versions of Granisetron is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from China, India, South Korea, Spain, Malta, Taiwan, and the United States, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Granisetron as an active ingredient.

Target supply price

The wholesale acquisition cost for granisetron intravenous solution (1 mg/mL) is around $18 for a supply of 1 milliliter(s). The retail price of 10 film-coated tablets (1Mg/film-coated tablet) of the substance in Europe reaches 30.74 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Granisetron manufacturers and suppliers that you are looking for. You can also find the dossier status of Granisetron and the GMP approvals of the different variants of the medication. The product description of all Granisetron suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Granisetron is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation